When detected early, Prostate Cancer survival rate is greater than 98%

How Do I Detect Prostate Cancer Early?

Get Started

What is Your Personalized Risk for Prostate Cancer?

Prostate Cancer remains the 2nd most leading cause of cancer-related deaths in men, despite being curable with early detection.3 Due to controversial recommendations about the common screening tool, called PSA screening, early detection rates and prostate cancer screenings are declining. At the same time, the number of men with an incurable disease is on the rise.4

Regular screening has been recommended if you are at high risk – but how do you know your individual risk? Relying on family history alone may not be enough.

Prompt Prostate Genetic Score(PGS) can help identify if you are at high risk.

Prompt the Conversation Today.

Using a simple cheek swab, Prompt PGS is able to identify those men at the highest risk of prostate cancer and empower them and their provider to take action by getting screened before it’s too late.

Get the test

  • 4x Increase in Metastatic Prostate Cancer

    Although annual PSA* screening is not recommended for everyone,5 metastatic prostate cancer has risen by 4x since the 2012 American Association of Family Practice recommendations against annual PSA screening.6

  • 3x More Efficient than Family History

    In a major prostate cancer trial, incorporating a Prompt PGS modified screening protocol would have identified 3x more patients at higher risk for developing prostate cancer than family history alone.7

  • 2x As Efficient as Annual PSA

    In that same trial, incorporating a Prompt PGS modified screening protocol would have been 2x as efficient as annual PSA screening, catching 20% more high grade cancer.8

  • 1x There is Only One You

    Prompt PGS provides a personalized genetic score for your likelihood of developing prostate cancer, so that you and your practitioner can determine the right screening protocol for you.

    Prompt PGS was based off REDUCE, PLCO, PCPT, and several other large clinical trials.

How It Works

  • Step 1

    Purchase your Prompt test kit online. If you are having the kit shipped, wait a few days for delivery.

  • Step 2

    Activate your kit online when you have in hand

  • Step 3

    Collect sample swab

  • Step 4

    Mail sample to lab to process results

  • Step 5

    Your healthcare practitioner will follow up with you to review the score and discuss screening options

What Our Customers Are Saying

  • “The Prompt test has provided definite relief and reassurance to me. I would encourage others to take the test and any necessary measures that might help them deal with the condition before it appears or worsens.”

    Steve E.

  • “I’m grateful that there are tests of this nature that can help us be especially vigilant about such a potentially dangerous disease.”

    Clive E.

Get My Personalized Score Today
  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018: CA: a cancer journal for clinicians. 2018;98(1):7-30
  2. Ahlering T, et al. Unintended consequences of decreased PSA-based prostate cancer screening. https://www.ncbi.nlm.nih.gov/pubmed/30003374 World J Urol. 2018 Jul 12. doi: 10.1007/s00345-018-2407-3.
  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018: CA: a cancer journal for clinicians. 2018;98(1):7-30
  4. Negoita S, Feuer EJ, Mariotto A, Cronin KA, Petkov VI, Hussey SK, et al. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Cancer. 2018;124(13):2801-14. 4. Ahlering T, et al. Unintended consequences of decreased PSA-based prostate cancer screening.
  5. American Academy of Family Physicians. Prostate cancer: clinical preventive service recommendation. 2012 (http://www.aafp.org/patient-care/clinical-recommendations/all/prostate-cancer.html)
  6. Ahlering T, et al. Unintended consequences of decreased PSA-based prostate cancer screening. https://www.ncbi.nlm.nih.gov/pubmed/30003374 World J Urol. 2018 Jul 12. doi: 10.1007/s00345-018-2407-3.
  7. In the Prostate Cancer Prevention Trial (PCPT trial), family history and annual PSA would have detected 26% of high grade cancers, while Prompt PGS would have detected 84% of high grade cancers.
  8. In the PCPT trial, annual PSA would have led to 11,262 screening events to detect 64% of all high grade cancers, while Prompt PGS would have led to 4,810 screening events to detect 84% of all high grade cancer
×